Phase 2/3 study with opaganib approved in Russia for COVID-19; United States trial rapidly enrolling Posted bylwm100 July 21, 2020July 21, 2020 Leave a comment on Phase 2/3 study with opaganib approved in Russia for COVID-19; United States trial rapidly enrolling https://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=2432&PID=0&IID=16275
